Cargando…
Osteopontin Blockade Immunotherapy Increases Cytotoxic T Lymphocyte Lytic Activity and Suppresses Colon Tumor Progression
SIMPLE SUMMARY: Despite the breakthrough in human cancer immunotherapy, colorectal cancer, except for the small subset of microsatellite instable colorectal cancer (MSI, ~4% total cases), is one of the few human cancers that does not respond to current immune checkpoint inhibitor (ICI) immunotherapy...
Autores principales: | Klement, John D., Poschel, Dakota B., Lu, Chunwan, Merting, Alyssa D., Yang, Dafeng, Redd, Priscilla S., Liu, Kebin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957528/ https://www.ncbi.nlm.nih.gov/pubmed/33670921 http://dx.doi.org/10.3390/cancers13051006 |
Ejemplares similares
-
Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation
por: Moorman, Hannah R., et al.
Publicado: (2020) -
IRF8 Regulates Intrinsic Ferroptosis through Repressing p53 Expression to Maintain Tumor Cell Sensitivity to Cytotoxic T Lymphocytes
por: Poschel, Dakota B., et al.
Publicado: (2023) -
WDR5-H3K4me3 epigenetic axis regulates OPN expression to compensate PD-L1 function to promote pancreatic cancer immune escape
por: Lu, Chunwan, et al.
Publicado: (2021) -
Restoring FAS Expression via Lipid-Encapsulated FAS DNA Nanoparticle Delivery Is Sufficient to Suppress Colon Tumor Growth In Vivo
por: Merting, Alyssa D., et al.
Publicado: (2022) -
p50 suppresses cytotoxic T lymphocyte effector function to regulate tumor immune escape and response to immunotherapy
por: Lu, Chunwan, et al.
Publicado: (2020)